ISIS Pharmaceuticals (Nasdaq: ISIS) is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
Recent Mentions on Fool.com
- 3 Biotech Stocks to Buy As the Greek Tragedy Unfolds
- Isis Pharmaceuticals Inc. Investors Can Finally Sense a Bright Future
- Why Isis Pharmaceuticals, Inc. Exploded Higher By 19% in May
- Biotech Investment Opportunities for the Long Term
- It's Partners and Pipeline Before Bean Counting at Isis Pharmaceuticals, Inc.